Search Results - Dul, CL

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract P3-07-67: Chemosensitivity and endocrine sensitivity predicted by MammaPrint and BluePrint in clinical luminal patients in the prospective NBRST study

    Abstract P3-07-67: Chemosensitivity and endocrine sensitivity predicted by MammaPrint and BluePrint in clinical luminal patients in the prospective NBRST study by Pellicane, JV, Whitworth, P, Beitsch, P, Baron, P, Beatty, J, Murray, MK, Dul, CL, Mislowsky, AM, Nash, CH, Richards, PD, Lee, LL, Stork-Sloots, L, de Snoo, F, Untch, S, Gittleman, M, Akbari, S, Rotkis, MC

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P4-14-10: Pertuzumab overcomes chemotherapy/trastuzumab resistance in ER+/Her2+ tumors classified as luminal functional subtype by the 80-gene BluePrint assay in the prospective neo-adjuvant breast registry symphony trial (NBRST)

    Abstract P4-14-10: Pertuzumab overcomes chemotherapy/trastuzumab resistance in ER+/Her2+ tumors classified as luminal functional subtype by the 80-gene BluePrint assay in the prosp... by Peter, B, Pat, W, Paul, B, Jennifer, B, Pellicane, JV, Murray, MK, Dul, CL, Mislowsky, AM, Nash, CH, Richards, PD, Lee, LL, Stork-Sloots, L, de Snoo, F, Untch, S, Gittleman, M, Akbari, S, Rotkis, MC

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P2-13-02: Radiation and depression associated with complications of tissue expander reconstruction

    Abstract P2-13-02: Radiation and depression associated with complications of tissue expander reconstruction by Wagner, RM, Spzunar, SM, Stefani, WA, Falk, JS, Williams, JL, Edhayan, E, Dul, CL, Rodriguez, D, Busuito, MJ, Browne, CH, Aref, A, Rabbani, AN, Chuba, PJ

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract P1-14-05: Three distinct HER2 subtypes identified by BluePrint 80-gene functional subtyping predict treatment-specific response in the prospective neo-adjuvant NBRST registry

    Abstract P1-14-05: Three distinct HER2 subtypes identified by BluePrint 80-gene functional subtyping predict treatment-specific response in the prospective neo-adjuvant NBRST regis... by Whitworth, P, Beitsch, P, Baron, P, Beatty, J, Pellicane, JV, Murray, MK, Dul, CL, Mislowsky, AM, Nash, CH, Richards, PD, Lee, LA, Stork-Sloots, L, de Snoo, F, Untch, S, Gittleman, M, Akbari, S, Rotkis, MC

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: